Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 225

    1.

    Association of serum proinsulin with hormone replacement therapy in nondiabetic older women: the Rancho Bernardo Study.

    Kim DJ, Barrett-Connor E.

    Diabetes Care. 2006 Mar;29(3):618-24.PMID: 16505516 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987.

    Ferrara A, Barrett-Connor E, Wingard DL, Edelstein SL.

    Diabetes Care. 1995 Feb;18(2):220-5.PMID: 7729301 [PubMed - indexed for MEDLINE]Related articles

    4.

    Type A behavior pattern, heart disease risk factors, and estrogen replacement therapy in postmenopausal women: the Rancho Bernardo Study.

    Buller JC, Kritz-Silverstein D, Barrett-Connor E, Wingard D.

    J Womens Health. 1998 Feb;7(1):49-56.PMID: 9511132 [PubMed - indexed for MEDLINE]Related articles

    5.

    Thiazide-associated metabolic abnormalities and estrogen replacement therapy: an epidemiological analysis of postmenopausal women in Rancho Bernardo, California.

    Saxman KA, Barrett-Connor EL, Morton DJ.

    J Clin Endocrinol Metab. 1994 May;78(5):1059-63.PMID: 8175960 [PubMed - indexed for MEDLINE]Related articles

    6.

    Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men. The Rancho Bernardo Study.

    Barrett-Connor E, Ferrara A.

    Diabetes Care. 1998 Aug;21(8):1236-9.PMID: 9702426 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Health status of users of hormone replacement therapy by hysterectomy status in Western Australia.

    Lambert LJ, Straton JA, Knuiman MW, Bartholomew HC.

    J Epidemiol Community Health. 2003 Apr;57(4):294-300.PMID: 12646547 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    GHb is a better predictor of cardiovascular disease than fasting or postchallenge plasma glucose in women without diabetes. The Rancho Bernardo Study.

    Park S, Barrett-Connor E, Wingard DL, Shan J, Edelstein S.

    Diabetes Care. 1996 May;19(5):450-6.PMID: 8732708 [PubMed - indexed for MEDLINE]Related articles

    9.

    The impact of insulin resistance on proinsulin secretion in pregnancy: hyperproinsulinemia is not a feature of gestational diabetes.

    Retnakaran R, Hanley AJ, Sermer M, Zinman B.

    Diabetes Care. 2005 Nov;28(11):2710-5.PMID: 16249544 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Hormone replacement therapy and glucose metabolism.

    Triusu RJ, Cowie CC, Harris MI.

    Obstet Gynecol. 2000 Nov;96(5 Pt 1):665-70.PMID: 11042298 [PubMed - indexed for MEDLINE]Related articles

    11.

    Association of hormone replacement therapy and carotid wall thickness in women with and without diabetes.

    Dubuisson JT, Wagenknecht LE, D'Agostino RB Jr, Haffner SM, Rewers M, Saad MF, Laws A, Herrington DM.

    Diabetes Care. 1998 Nov;21(11):1790-6.PMID: 9802722 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study.

    Oh JY, Barrett-Connor E, Wedick NM, Wingard DL; Rancho Bernardo Study.

    Diabetes Care. 2002 Jan;25(1):55-60.PMID: 11772901 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    The effect of estrogen use on levels of glucose and insulin and the risk of type 2 diabetes in american Indian postmenopausal women : the strong heart study.

    Zhang Y, Howard BV, Cowan LD, Yeh J, Schaefer CF, Wild RA, Wang W, Lee ET.

    Diabetes Care. 2002 Mar;25(3):500-4.PMID: 11874937 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition.

    Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Connelly PW, Zinman B.

    Diabetes Care. 2001 Jul;24(7):1240-7. Erratum in: Diabetes Care 2001 Oct;24(10):1851. PMID: 11423509 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.

    Windler E, Zyriax BC, Eidenmüller B, Boeing H.

    Maturitas. 2007 Jul 20;57(3):239-46. Epub 2007 Feb 9.PMID: 17292571 [PubMed - indexed for MEDLINE]Related articles

    17.

    Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study.

    Mooy JM, Grootenhuis PA, de Vries H, Kostense PJ, Popp-Snijders C, Bouter LM, Heine RJ.

    Diabetologia. 1996 Mar;39(3):298-305.PMID: 8721775 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: the Rancho Bernardo Study.

    Goodman-Gruen D, Barrett-Connor E.

    J Clin Endocrinol Metab. 1996 Dec;81(12):4268-71.PMID: 8954026 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of sulphonylurea therapy on plasma insulin, intact and 32/33 split proinsulin in subjects with type 2 diabetes mellitus.

    Davies MJ, Metcalfe J, Day JL, Grenfell A, Hales CN, Gray IP.

    Diabet Med. 1994 Apr;11(3):293-8.PMID: 8033529 [PubMed - indexed for MEDLINE]Related articles

    20.

    Serum proinsulin levels are disproportionately increased in elderly prediabetic subjects.

    Mykkänen L, Haffner SM, Kuusisto J, Pyörälä K, Hales CN, Laakso M.

    Diabetologia. 1995 Oct;38(10):1176-82.PMID: 8690169 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data